
    
      Primary:

      To evaluate the efficacy of ONCOXIN on oral mucositis symptoms in patients who receive
      chemotherapy and/or radiotherapy.

      Secondary:

      To evaluate the effects of ONCOXIN on nutritional status in patients who receive chemotherapy
      and/or radiotherapy.
    
  